| Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
|---|
| 05/18/2006 | WO2005001112A3 RIBOSOMAL RNA METHYLTRANSFERASES R1mA: TARGET VALIDATION AND PROCESSES FOR DEVELOPING AN INHIBITOR ASSAY AND IDENTIFICATION CANDIDATE INHIBITORS |
| 05/18/2006 | WO2003100082A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105337 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1656133A2 Mitotic kinesin inhibitors |
| 05/11/2006 | WO2005024042A3 Aptamers and methods for their in vitro selection and uses thereof |
| 05/11/2006 | WO2005007869A3 Assays for the direct measurement of gene dosage |
| 05/11/2006 | US20060099610 Method and kit for detecting a risk of acute myocardial infarction |
| 05/11/2006 | US20060099572 Contacting each of a plurality of reagents in separate compartments with compound, wherein each reagent has a predetermined concentration of two types of precipitating agents comprising salt and polyoxyethylene glycol; human immunodeficiency polypeptide viral polypeptides; |
| 05/10/2006 | EP1567860A4 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/10/2006 | CN1255551C Method of detection of nucleic acids with a specific sequence composition |
| 05/04/2006 | WO2005024046A3 Methods of detection and notification of bioagent contamination |
| 05/04/2006 | US20060093590 Pseudotyped retroviruses |
| 05/03/2006 | EP1651779A2 Method for rapid identification of alternative splicing |
| 05/03/2006 | EP1490486A4 Method of identifying genes controlling diferentiation |
| 05/03/2006 | CN1766111A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 05/02/2006 | US7037660 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 04/27/2006 | WO2005059158A3 Magnetized scleral buckle with polymerizing magnetic polymers |
| 04/27/2006 | WO2005052181A3 Methods for molecular toxicology modeling |
| 04/27/2006 | WO2005045057A3 Methods for diagnosing bipolar and unipolar disorder |
| 04/27/2006 | WO2005034853A3 Uses of interferons with altered spatial structure |
| 04/27/2006 | US20060088836 Methods and compositions for diagnosing and monitoring transplant rejection |
| 04/26/2006 | EP1649040A2 Assays for the direct measurement of gene dosage |
| 04/26/2006 | EP1649039A2 Crystallization reagent matrices and related methods and kits |
| 04/26/2006 | EP1649037A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 04/20/2006 | WO2006040409A1 Method and kit for detecting a risk of acute myocardial infarction |
| 04/20/2006 | WO2004097027A3 Screening of biocatalysts in plants |
| 04/19/2006 | EP1647599A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 04/13/2006 | WO2005042759A3 Expression profiling using microarrays |
| 04/13/2006 | WO2005014850A3 Systems and methods for analyzing nucleic acid sequences |
| 04/13/2006 | WO2004108947A3 Biological terrain management |
| 04/13/2006 | US20060078468 Modification of selectivity for sensing for nanostructure device arrays |
| 04/12/2006 | EP1644738A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 04/12/2006 | EP1644536A2 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 04/12/2006 | EP1644530A2 Methylated gene biomarkers for detecting cancer |
| 04/12/2006 | EP1644525A2 Detection of a target in a preservative solution |
| 04/12/2006 | EP1644513A2 Assay and kits for detecting protein binding |
| 04/12/2006 | CN1250744C Method of determining di-hydro-pyrimidine de-hydrogenase gene expression |
| 04/06/2006 | WO2005033328A3 Compositions and processes for genotyping single nucleotide polymorphisms |
| 04/06/2006 | WO2005001109A3 Methods and compositions to detect microbes in fecal samples |
| 04/06/2006 | WO2004044225A3 Methods for identifying dna copy number changes |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1641930A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 04/05/2006 | EP1641923A2 Nadks as modifiers of branching morphogenesis and methods of use |
| 04/05/2006 | EP1641492A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 03/30/2006 | WO2005042767A3 Compositions and methods for detecting severe acute respiratory syndrome coronavirus |
| 03/30/2006 | WO2005026380A3 Bone marrow proliferation assay |
| 03/30/2006 | US20060068456 Methods for screening and identifying compounds |
| 03/29/2006 | EP1639132A2 Oligonucleotide ligation assay by detecting released pyrophosphate |
| 03/29/2006 | EP1639121A2 Synthesis of beta -l-2-deoxy nucleosides |
| 03/29/2006 | EP1222467B1 Leptin assay based on detecting ang-2 expression |
| 03/28/2006 | US7019017 Small molecule inhibitors of HER2 expression |
| 03/28/2006 | US7018816 Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism |
| 03/23/2006 | WO2006031181A1 Methods for identifying a patient as a candidate for treatment with a long acting beta agonist and for predicting a patient’s response to long acting beta2 agonist therapy by analysing polymorphisms in the beta2-adrenergic receptor gene |
| 03/23/2006 | WO2004104214A3 Methods and devices for multiplexing amplification reactions |
| 03/23/2006 | WO2004094648A3 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 03/23/2006 | WO2003082202A3 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 03/22/2006 | EP1636373A2 Biochip devices for ion transport measurement, methods of manufacture, and methods of use |
| 03/22/2006 | EP1636354A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 03/22/2006 | EP1587945A4 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 03/16/2006 | WO2005012546A3 Methods for isolating and identifying novel target-specific structuremers for use in the biological sciences |
| 03/16/2006 | WO2004113553A3 Method of producing pure amidites and oligonucleotides |
| 03/16/2006 | US20060057721 Identifying agents which modulate cell death, indicated by the expression of caspase-2 and/or caspase-7, in Glial cell line-derived neurotrophic factor (GDNF) family growth factor deprived neuronal or nonneuronal cells |
| 03/16/2006 | US20060057628 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 03/16/2006 | US20060057568 Method of identifying compounds that alter bag-1 mediated down-regulation of glucocorticoid-receptor transactivation |
| 03/15/2006 | EP1634074A2 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 03/15/2006 | EP1546983A4 Controlled aligment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading |
| 03/09/2006 | WO2006025791A1 Sars detection |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/07/2006 | US7008764 Optimization of cells for endogenous gene activation |
| 03/02/2006 | WO2005026375A3 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/02/2006 | WO2004083447A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 03/02/2006 | WO2004059289A3 Target-dependent transcription using deletion mutants of n4 rna polymerase |
| 03/02/2006 | DE112004000338T5 System und Verfahren zum Verarbeiten identifizierter Metaboliten System and method for processing of identified metabolites |
| 03/01/2006 | EP1629114A2 Method for detecting toxic and non-toxic cyanobacteria |
| 03/01/2006 | EP1629108A2 Homogeneous multiplex screening assays and kits |
| 02/28/2006 | US7005278 Comprises replication of oligonucleotides for detection, diagnosis and treatment of cancer using 5-Fluorouracil-based chemotherapeutic regimen |
| 02/23/2006 | WO2005003372A3 Mylks as modifiers of branching morphogenesis and methods of use |
| 02/16/2006 | WO2005052180A3 Ntrk1 genetic markers associated with progression of alzheimer’s disease |
| 02/16/2006 | WO2004083448A3 Molecular differences between species of the m.tuberculosis complex |
| 02/16/2006 | US20060035240 Optimization of gene expression analysis using immobilized capture probes |
| 02/16/2006 | US20060035228 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 02/15/2006 | EP1625395A1 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/08/2006 | EP1623020A2 Genomic and proteomic approaches for the development of cell culture medium |
| 02/08/2006 | EP1623009A2 Transfection kinetics and structural promoters |
| 02/07/2006 | US6996474 Automated method for identifying related biomolecular sequences |
| 02/07/2006 | US6994956 combining with radiolabelled substrate, adding phase-partition scintillation fluid, then incubating within single vessel comprising multiwell plates; for screening compounds for treatment of diabetes, obesity, cardiovascular disease, and cancer |
| 02/02/2006 | WO2005014846A3 Methods for identifying risk of breast cancer and treatments thereof |
| 02/02/2006 | WO2004113503A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 02/02/2006 | US20060024707 Luminescent polymers and methods of use thereof |
| 02/01/2006 | EP1620574A2 Method for nucleic acid sequencing |
| 02/01/2006 | EP1620566A2 Apparatus for the automated synthesis of polynucleotides |
| 02/01/2006 | EP1620564A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 02/01/2006 | EP1620562A2 Modulation of telomere-initiated cell signaling |
| 02/01/2006 | EP1620125A2 Tolerance to graft following thymic reactivation |
| 02/01/2006 | EP1619952A2 Tolerance to graft prior to thymic regeneration |